RASA1 and neoplasm: Another interesting candidate tumor suppressor gene in aggressive cSCC is RAS p21 protein activator 1 (RASA1), found mutated in 13% of analyzed cases, with 66% of its mutations predicted to truncate or eliminate the protein [28].